author-photo

Xiao X. Wei

University of California, San Francisco

12

Papers

178

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer

2019 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (14)
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade

2019 Immunity
Show All
- Source
- Cite
- Save
Citations (53)
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study

2019 Clinical Genitourinary Cancer
Show All
- Source
- Cite
- Save
Citations (11)
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer

2018 Oncologist
Show All
- Source
- Cite
- Save
Citations (11)
A phase II study of itraconazole in biochemically recurrent prostate cancer.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer

2017 Oncologist
Show All
- Source
- Cite
- Save
Citations (29)
Treatment strategies in low-volume metastatic castration-resistant prostate cancer

2017 Current Opinion in Urology
Show All
- Source
- Cite
- Save
Citations (6)
Prospects for the use of ipilimumab in treating advanced prostate cancer

2016 Expert Opinion on Biological Therapy
Show All
- Source
- Cite
- Save
Citations (5)
Abstract 276: Recruitment of effector T cells into the tumor rim and center with neoadjuvant systemic GM-CSF in patients with localized prostate cancer

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)